Mr. Rowland has been a member of the board since March. He will replace the company’s founder and current CEO Elazar Sonnenschein, MD, upon shareholder approval.
Mr. Rowland served for 17 years as a manager for Boston Scientific and has 24 years of experience in the life sciences market.
Medigus develops minimally invasive endoscopic techniques for gastroesophageal reflux disease treatment.
More Articles on Gastroenterology:
GI, Endoscopy Video Journal Released by Elsevier
Study: Probiotics May Not Relieve Antibiotic-Associated Diarrhea in Elderly
European Researchers Zero In On Possible Bowel Disease Cause
